158 related articles for article (PubMed ID: 30899413)
21. Histone methyltransferase Dot1L is a coactivator for thyroid hormone receptor during
Wen L; Fu L; Shi YB
FASEB J; 2017 Nov; 31(11):4821-4831. PubMed ID: 28739643
[TBL] [Abstract][Full Text] [Related]
22. DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines.
Oktyabri D; Ishimura A; Tange S; Terashima M; Suzuki T
Biochimie; 2016 Apr; 123():20-31. PubMed ID: 26783998
[TBL] [Abstract][Full Text] [Related]
23. DOT1L Activity Promotes Proliferation and Protects Cortical Neural Stem Cells from Activation of ATF4-DDIT3-Mediated ER Stress In Vitro.
Roidl D; Hellbach N; Bovio PP; Villarreal A; Heidrich S; Nestel S; Grüning BA; Boenisch U; Vogel T
Stem Cells; 2016 Jan; 34(1):233-45. PubMed ID: 26299268
[TBL] [Abstract][Full Text] [Related]
24. DOT-1.1 (DOT1L) deficiency in
Liontis T; Verma K; Grishok A
BBA Adv; 2023; 3():100080. PubMed ID: 37082252
[TBL] [Abstract][Full Text] [Related]
25. The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases.
Tao M; Shi Y; Chen H; Li J; Wang Y; Ma X; Du L; Wang Y; Yang X; Hu Y; Zhou X; Zhong Q; Yan D; Qiu A; Zhuang S; Liu N
Mol Biomed; 2024 Jan; 5(1):3. PubMed ID: 38172378
[TBL] [Abstract][Full Text] [Related]
26. The protective role of DOT1L in UV-induced melanomagenesis.
Zhu B; Chen S; Wang H; Yin C; Han C; Peng C; Liu Z; Wan L; Zhang X; Zhang J; Lian CG; Ma P; Xu ZX; Prince S; Wang T; Gao X; Shi Y; Liu D; Liu M; Wei W; Wei Z; Pan J; Wang Y; Xuan Z; Hess J; Hayward NK; Goding CR; Chen X; Zhou J; Cui R
Nat Commun; 2018 Jan; 9(1):259. PubMed ID: 29343685
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of DOT1L by Half-Selenopsammaplin A Analogs Suppresses Tumor Growth and EMT-Mediated Metastasis in Triple-Negative Breast Cancer.
Byun WS; Lee GH; Park HG; Lee SK
Pharmaceuticals (Basel); 2020 Dec; 14(1):. PubMed ID: 33379275
[TBL] [Abstract][Full Text] [Related]
28. Deletion of the prorenin receptor in the ureteric bud in mice inhibits Dot1/H3K79 pathway.
Song R; Yosypiv IV
Pediatr Res; 2024 Jan; ():. PubMed ID: 38287105
[TBL] [Abstract][Full Text] [Related]
29. Primitive Erythropoiesis in the Mouse is Independent of DOT1L Methyltransferase Activity.
Malcom CA; Ratri A; Piasecka-Srader J; Borosha S; Chakravarthi VP; Alvarez NS; Vivian JL; Fields TA; Karim Rumi MA; Fields PE
Front Cell Dev Biol; 2021; 9():813503. PubMed ID: 35111761
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic drug library screening reveals targeting DOT1L abrogates NAD
Gu X; Hua Y; Yu J; Yang L; Ge S; Jia R; Chai P; Zhuang A; Fan X
J Pharm Anal; 2023 Jan; 13(1):24-38. PubMed ID: 36820078
[TBL] [Abstract][Full Text] [Related]
31. The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness.
Kari V; Raul SK; Henck JM; Kitz J; Kramer F; Kosinsky RL; Übelmesser N; Mansour WY; Eggert J; Spitzner M; Najafova Z; Bastians H; Grade M; Gaedcke J; Wegwitz F; Johnsen SA
Clin Epigenetics; 2019 Jan; 11(1):4. PubMed ID: 30616689
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the DOT1L network: implications of diverse roles for DOT1L.
Park G; Gong Z; Chen J; Kim JE
Protein J; 2010 Apr; 29(3):213-23. PubMed ID: 20431927
[TBL] [Abstract][Full Text] [Related]
33. DOT1L regulates dystrophin expression and is critical for cardiac function.
Nguyen AT; Xiao B; Neppl RL; Kallin EM; Li J; Chen T; Wang DZ; Xiao X; Zhang Y
Genes Dev; 2011 Feb; 25(3):263-74. PubMed ID: 21289070
[TBL] [Abstract][Full Text] [Related]
34. The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells.
Salvati A; Gigantino V; Nassa G; Giurato G; Alexandrova E; Rizzo F; Tarallo R; Weisz A
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31689915
[TBL] [Abstract][Full Text] [Related]
35. Computer-Aided Discovery of Massonianoside B as a Novel Selective DOT1L Inhibitor.
Chen J; Park HJ
ACS Chem Biol; 2019 May; 14(5):873-881. PubMed ID: 30951287
[TBL] [Abstract][Full Text] [Related]
36. Dot1l cooperates with Npm1 to repress endogenous retrovirus MERVL in embryonic stem cells.
Zhao X; Li X; Sun H; Zhao X; Gao T; Shi P; Chen F; Liu L; Lu X
Nucleic Acids Res; 2023 Sep; 51(17):8970-8986. PubMed ID: 37522386
[TBL] [Abstract][Full Text] [Related]
37. DOT1L Mediated Gene Repression in Extensively Self-Renewing Erythroblasts.
Borosha S; Ratri A; Ghosh S; Malcom CA; Chakravarthi VP; Vivian JL; Fields TA; Rumi MAK; Fields PE
Front Genet; 2022; 13():828086. PubMed ID: 35401699
[TBL] [Abstract][Full Text] [Related]
38. DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma.
Hou Y; Huang S; Liu J; Wang L; Yuan Y; Liu H; Weng X; Chen Z; Hu J; Liu X
Am J Cancer Res; 2023; 13(1):276-292. PubMed ID: 36777512
[TBL] [Abstract][Full Text] [Related]
39. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
40. ES cell cycle progression and differentiation require the action of the histone methyltransferase Dot1L.
Barry ER; Krueger W; Jakuba CM; Veilleux E; Ambrosi DJ; Nelson CE; Rasmussen TP
Stem Cells; 2009 Jul; 27(7):1538-47. PubMed ID: 19544450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
